eGlint
PrivateLast Round
Seed
Nov 1, 2021
Total Funding Raised
$2.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
eGlint is a biotechnology company that develops ProteoNex, a rapid, multiplexed proteomics platform designed for real-time biomarker measurement from blood samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eGlint Comparables
Compare eGlint with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nomic Bio | 77% | |
| Alamar Biosciences | 73% | |
| Standard BioTools | 71% |
eGlint Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2021 |
Key People
Founding team and executive leadership
eGlint Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Seed |
| Breakthrough Energy Ventures | Seed |
| Lakestar | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| Emerald Bioventures | Seed |
| Half Court Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 975% MoM, reaching 1.7K.
- May 15, 2026
Monthly visitors grew 65% MoM, from 763 to 1.3K.
Recent news
Latest coverage and updates
- integrates_withOct 9, 2026
eGlint integrates its ProteoCare(TM) biosensing technology with Siomyx, Inc.'s CMOS biochips
- recognized_asSep 24, 2026
eGlint recognized as one of four finalists at BioTools Innovator Capstone on Sep 24th '26.
eGlint Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about eGlint's valuation, stock price, and market status.
Is eGlint a public or private company?
eGlint is a private company.
What is the current stock price of eGlint?
eGlint is a private company with no public stock price. Caplight tracks eGlint's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is eGlint worth (valuation)?
Valuation information for eGlint is not publicly available.
Can I buy eGlint stock?
eGlint shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was eGlint's last funding round?
eGlint's most recent funding round was Seed on November 1, 2021.
Who are the main investors in eGlint?
Key investors in eGlint include MedTech Innovator, Breakthrough Energy Ventures, Lakestar, Ulu Ventures, SeedFolio.
Will eGlint IPO soon?
No public IPO plans have been announced for eGlint.
How can I track eGlint secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eGlint's secondary market activity and sign up for updates.